Selected References:

  • Alhussien A, et al. 2018. Safety of intranasal corticosteroid sprays during pregnancy: and updated Review. Eur Arch Otorhinolaryngol. 275(2):325-333.
  • Bakhireva LN, et al. 2005. Asthma medication use in pregnancy and fetal growth. Allergy Clin Immunol 116(3):503-509.
  • Bay Bjørn AM, et al. 2014. Use of corticosteroids in early pregnancy is not associated with risk of oral clefts and other congenital malformations in offspring. Am J Ther; 21(2):73-80.
  • Bérard A, et al. 2016. Intranasal triamcinolone use during pregnancy and the risk of adverse pregnancy outcomes. Journal of Allergy and Clinical Immunology 136(1):97-104.
  • Blais L, et al. 2007. Use of inhaled corticosteroids during the first trimester of pregnancy and the risk of congenital malformations among women with asthma. Thorax 62:320-328.
  • Blais L, et al. 2009. High doses of inhaled corticosteroids during the first trimester of pregnancy and congenital malformations. J Allergy Clin Immunol 124(6):1229-1234.
  • Charlton RA, et al. 2015. Safety of fluticasone propionate prescribed for asthma during pregnancy: A UK population-based cohort study. J Allergy Clin Immunol Pract; 3(5):772-9.e3.
  • Cossette B, et al. 2013. Impact of maternal use of asthma-controller therapy on perinatal outcomes. Thorax; 68(8):724-30.
  • Ellsworth A. 1994. Pharmacotherapy of asthma while breastfeeding. J Hum Lact; 10:39-41.
  • Fält A, et al. 2007. Exposure of infants to budesonide through breast milk of asthmatic mothers. J Allergy Clin Immunol 120(4):798-802.
  • Greenberger PA, Patterson R. 1983. Beclomethasone dipropionate for severe asthma during pregnancy. Ann Internal Med 98:478-480.
  • Källén B, et al. 1999. Congenital malformations after the use of inhaled budesonide in early pregnancy. Obstet Gynecol 93(3):392-395.
  • Lim AS, et al. 2011. Management of asthma in pregnant women by general practitioners: A cross sectional survey BMC Family Practice 12:12
  • Namazy J, et al. 2004. Use of inhaled steroids by pregnant asthmatic women does not reduce intrauterine growth. J Allergy Clin Immunol 113(3):427-432.
  • Norjavaara E and Gerhardsson de Verdier MG. 2003. Normal pregnancy outcomes in a population-based study including 2968 pregnant women exposed to budesonide. J Allergy Clin Immunol 111(4):736-742.
  • Rocklin RE, 2011. Asthma, asthma medications and their effects on maternal/fetal outcomes during pregnancy. Reproductive Toxicology 32 (2011) 189–197
  • Schatz M, et al. 2004. The relationship of asthma medication use to perinatal outcomes. J Allergy Clin Immunol 113(6):1040-1045.
  • Steinberg JA. 2015. Perception versus reality: the saga of inhaled asthma controller medication and fetal risk. J Allergy Clin Immunol; 135(1):131-2.